• Weekly Pharma News Review | PharmaSources.com (April.4th-April.8th) PharmaSources.com
    April 12, 2022
    This week, the release of Phase III clinical data for treating outpatients infected with mild and moderate COVID-19 with Kintor Pharmaceuticals' proxalutamide sparked an intense interest. The pharma news review of this week covers a total of 18 pieces of
PharmaSources Customer Service